Authors

Filippo Gabbia served Johnson & Johnson Medical for 21 years. He had the opportunity to cover several sales and marketing roles that contributed to developing solid skills in public business market access across EMEA. During the past 5 years, he developed a Strategic Tendering approach aimed at supporting different J&J Franchises to implement appropriate pre-tender […]

Sandra is a Senior Public Affairs & Market Access professional with over 16 years of experience in working in European Government Affairs, Patient Advocacy & Market Access areas in the pharmaceutical & medical device industry. Since Oct 2015 she is with Baxter where she is leading the Government Policy, Advocacy & Reimbursement for the EMEA […]

Louis P. Garrison, Jr., PhD, is Professor in the Pharmaceutical Outcomes Research and Policy Program in the School of Pharmacy, and Adjunct Professor in the Departments of Global Health and Health Services at the University of Washington, where he joined the faculty in 2004. He also co-directs the Global Medicines Program in Global Health. Dr. […]

Chair – Committee on Outcomes-Based Healthcare Systems, European Health Parliament  Senior Consultant – Healthcare, Porter Novelli Brussels

Martyna Giedrojc is Director International Public Affairs and Professionals Relations Europe at Cepheid. Prior to her current role she has been working for London-based Public Affairs consultancies and advised clients on health policy issues. She is passionate about the societal value of medical technologies, digital health and innovation. Martyna has almost a decade of relevant […]

Michael leads the acute ischemic stroke R&D portfolio as General Manager of the CERENOVUS Neuro Technology Centre (Galway Ireland). Prior to the Johnson & Johnson acquisition of Neuravi, Michael was Vice President of R&D and Technical Operations where he led the development and manufacture of the EMBOTRAP® II Revascularization Device. In Neuravi, he was the […]

Mr. Goblirsch is a former head of a unit in Stockholm County Council and worked mainly with procurement of medical equipment for the new hospital buildings NKS (New Karolinska Solna). Mr. Goblirsch has more than 30 years of experience of purchasing in the world of medical equipment. In 2009 he was elected purchaser of the […]

Professor González-Moreno, born in Segovia, Spain on May 31 1968, is married and has 3 children. He completed his general surgery residency in Hospital Universitario “12 de Octubre” (Madrid). He continued his training in gastrointestinal surgical oncology as a clinical fellow for two years under Dr. Paul H. Sugarbaker at the Washington Cancer Institute in […]

Professor Mary K. Gospodarowicz’s record of service in the Union for International Cancer Control (UICC) stretches back two decades. She has been active since 1990 in UICC’S work on cancer staging, currently chairing the TNM Prognostic Factors Project. She edited three editions of Prognostic Factors in Cancer (3rd edition, August 2006) and the seventh edition […]

Furio Gramatica, physicist by training, is Director of Development & Innovation at Don Gnocchi Foundation, an Italian chain of healthcare and research centres specialized in post-acute medicine. In this role, he is responsible for the integration and translation of innovative solutions – from research and industry – into clinical practice and for developing alliances with […]

Meet Philippa Gray, an accomplished Medtech industry leader. With a career spanning over 15 years, Philippa has consistently showcased exceptional leadership and expertise in research and development, particularly in program management. A distinguished graduate of the University of California San Diego, where she earned a degree in Mechanical Engineering, Philippa embarked on a journey that […]